Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels |
---|---|---|---|---|
1 | ||||
Atrial fibrillation | Atrial fibrillation | 12.2% - 21.3% | x | |
Nausea | Nausea | postmarketing, 4.8% - 21.3% | x | |
Headache | Headache | 6.3% | x | |
Renal failure acute | Renal failure acute | 1.96% - 9.43% | x | |
Vomiting | Vomiting | 3.2% | x | |
Hypersensitivity | Hypersensitivity | postmarketing | x | |
Hypotension | Hypotension | postmarketing | x | |
Oxygen saturation decreased | Oxygen saturation decreased | postmarketing | x | |
Blood triglycerides increased | Blood triglycerides increased | postmarketing | x | |
Ileus | Ileus | postmarketing | x | |
Tachycardia | Reflex tachycardia | postmarketing | x | |
Dyspnoea | Dyspnoea | x | ||
Myocardial infarction | Myocardial infarction | x | ||
Acute coronary syndrome | Myocardial infarction | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |